First Manhattan’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.4M | Sell |
1,697,334
-3,213,883
| -65% | -$175M | 0.18% | 66 |
|
|
2026
Q1 | $308M | Buy |
4,911,217
+3,029,280
| +161% | +$242M | 0.85% | 27 |
|
|
2025
Q4 | $179M | Buy |
1,881,937
+1,696,478
| +915% | +$166M | 0.47% | 38 |
|
|
2025
Q3 | $18.1M | Buy |
185,459
+163
| +0.1% | +$16.9K | 0.05% | 119 |
|
|
2025
Q2 | $19.9M | Sell |
185,296
-1,976
| -1% | -$200K | 0.06% | 115 |
|
|
2025
Q1 | $18.9M | Sell |
187,272
-2,551
| -1% | -$257K | 0.06% | 112 |
|
|
2024
Q4 | $17M | Sell |
189,823
-8,185
| -4% | -$721K | 0.05% | 114 |
|
|
2024
Q3 | $16.6M | Sell |
198,008
-113,605
| -36% | -$8.96M | 0.05% | 111 |
|
|
2024
Q2 | $24M | Sell |
311,613
-317
| -0.1% | -$23.2K | 0.08% | 96 |
|
|
2024
Q1 | $21.4M | Sell |
311,930
-152,866
| -33% | -$9.83M | 0.07% | 95 |
|
|
2023
Q4 | $26.9M | Sell |
464,796
-135,646
| -23% | -$7.24M | 0.09% | 84 |
|
|
2023
Q3 | $31.7M | Hold |
600,442
| – | – | 0.12% | 75 |
|
|
2023
Q2 | $32.5M | Buy |
600,442
+225
| +0% | +$11.8K | 0.12% | 74 |
|
|
2023
Q1 | $30M | Sell |
600,217
-468
| -0.1% | -$22.1K | 0.12% | 80 |
|
|
2022
Q4 | $27.8M | Sell |
600,685
-2,632
| -0.4% | -$114K | 0.1% | 84 |
|
|
2022
Q3 | $23.4M | Buy |
603,317
+4,150
| +0.7% | +$166K | 0.1% | 88 |
|
|
2022
Q2 | $22.3M | Sell |
599,167
-14,700
| -2% | -$598K | 0.09% | 99 |
|
|
2022
Q1 | $27.2M | Sell |
613,867
-11,125
| -2% | -$482K | 0.09% | 97 |
|
|
2021
Q4 | $26.5M | Hold |
624,992
| – | – | 0.09% | 97 |
|
|
2021
Q3 | $27.1M | Hold |
624,992
| – | – | 0.1% | 91 |
|
|
2021
Q2 | $26.7M | Hold |
624,992
| – | – | 0.1% | 97 |
|
|
2021
Q1 | $24.2M | Hold |
624,992
| – | – | 0.1% | 97 |
|
|
2020
Q4 | $22.5M | Buy |
624,992
+99,967
| +19% | +$3.6M | 0.11% | 96 |
|
|
2020
Q3 | $20.1M | Sell |
525,025
-601
| -0.1% | -$23.2K | 0.1% | 95 |
|
|
2020
Q2 | $18.5M | Sell |
525,626
-8,550
| -2% | -$308K | 0.11% | 98 |
|
|
2020
Q1 | $17.4M | Buy |
534,176
+531,941
| +23,800% | +$20.8M | 0.11% | 98 |
|
|
2019
Q4 | $101K | Buy |
2,235
+1,750
| +361% | +$73.2K | ﹤0.01% | 789 |
|
|
2019
Q3 | $19K | Hold |
485
| – | – | ﹤0.01% | 1051 |
|
|
2019
Q2 | $20K | Buy |
485
+75
| +18% | +$2.88K | ﹤0.01% | 1075 |
|
|
2019
Q1 | $15K | Buy |
+410
| New | +$15.7K | ﹤0.01% | 1144 |
|
|
2018
Q4 | – | Sell |
-500
| Closed | -$19K | – | 1366 |
|
|
2018
Q3 | $19K | Buy |
+500
| New | +$17.5K | ﹤0.01% | 1130 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$2K | – | 1383 |
|
|
2017
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 1377 |
|
|
2017
Q3 | $2K | Buy |
+100
| New | +$2.76K | ﹤0.01% | 1357 |
|
|
2013
Q4 | – | Sell |
-300
| Closed | -$3K | – | 1370 |
|
|
2013
Q3 | $3K | Sell |
300
-3,000
| -91% | -$32.5K | ﹤0.01% | 1266 |
|
|
2013
Q2 | $36K | Buy |
+3,300
| New | +$28K | ﹤0.01% | 984 |
|
Other funds holding BSX
First Manhattan's BSX Position: Q2 2026 in Review
First Manhattan reduced its Boston Scientific (BSX) stake by 65% in Q2 2026, selling an estimated $175M and leaving 1,697,334 shares worth $72.4M. The position accounts for 0.18% of the portfolio, ranked #66.
First Manhattan first reported a position in BSX in Q2 2013 and has held it in 35 quarters since. The position peaked at $308M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- First Manhattan held 1,697,334 shares of Boston Scientific worth $72.4M as of Q2 2026.
- First Manhattan sold 3,213,883 Boston Scientific shares in Q2 2026, an estimated $175M.
- Boston Scientific made up 0.18% of First Manhattan's portfolio in Q2 2026, its #66 holding.
- First Manhattan first reported a position in Boston Scientific in Q2 2013 and has held it in 35 quarters since.
- First Manhattan's Boston Scientific position peaked at $308M in Q1 2026.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on First Manhattan's 13F filing for Q2 2026, filed 14 Aug 2026.